|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2003; 42:296-300, doi:10.1016/S0735-1097(03)00623-5 © 2003 by the American College of Cardiology Foundation |
* Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
Manuscript received January 14, 2003; revised manuscript received April 11, 2003, accepted April 17, 2003.
* Reprint requests and correspondence: Dr. Nasser M. Lakkis, Section of Cardiology, Department of Medicine, Baylor College of Medicine, 6550 Fannin, SM 677, Houston, Texas 77030, USA.
nlakkis{at}bcm.tmc.edu
OBJECTIVES: The purpose of this paper is to examine the incidence and determinants of permanent complete heart block (CHB) after nonsurgical septal reduction therapy (NSRT), and to evaluate the clinical impact of permanent pacemaker (PPM) placement.
BACKGROUND: Nonsurgical septal reduction therapy with ethanol improves the clinical and hemodynamic parameters in patients with symptomatic hypertrophic obstructive cardiomyopathy. Complete heart block is a common complication after NSRT.
METHODS: The database of 261 consecutive patients who underwent NSRT at Baylor College of Medicine was reviewed. Clinical variables that were considered as possible determinants for CHB after NSRT were: age, gender, New York Heart Association (NYHA) functional class, left ventricular outflow tract (LVOT) gradient at rest or with provocation, septal thickness, and baseline exercise duration. For electrocardiographic (ECG) variables, the presence of first-degree atrioventricular (AV) block, bifascicular block, left bundle branch block, atrial fibrillation, and left ventricular hypertrophy were analyzed. In addition, the volume of ethanol injected, the method of administration of ethanol (i.e., bolus vs. slow injection [over 30 to 60 s]), number of septal arteries occluded, use of myocardial echocardiography, and infarct size as determined by peak creatine kinase level.
RESULTS: Of 261 consecutive patients, 37 had PPM or automatic implantable cardiac defibrillator placed before NSRT. Of the remaining 224 patients, 31 (14%) developed CHB after the procedure. Multivariate logistic regression analysis showed that female gender (odds ratio [OR] 4.3; p = 0.02), bolus injection of ethanol (OR 51; p = 0.004), injecting more than one septal artery (OR 4.6; p = 0.016), the presence of left bundle branch block (OR 39; p = 0.002), and first-degree AV block (OR 14; p = 0.001) on the baseline ECG are independent predictors of CHB after NSRT. Patients requiring PPM placement had a similar improvement in their NYHA functional class, septal thickness reduction, LVOT gradient reduction, and improvement of exercise capacity when compared with patients who did not require pacing.
CONCLUSIONS: Multiple demographic, electrocardiographic, and technical factors seem to increase the risk of CHB after NSRT. Patients with CHB after NSRT derive similar clinical and hemodynamic benefit to patients who did not require permanent pacing.
| ||||||||||||||||||||||||
This article has been cited by other articles:
|
|
 |
|
  M. Togni, M. Billinger, S. Cook, and O. M. Hess Septal myectomy: cut, coil, or boil? Eur. Heart J., February 1, 2008; 29(3): 296 - 298. [Full Text] [PDF]
|
|
|
|
|
|
E. Durand, E. Mousseaux, P. Coste, R. Pilliere, O. Dubourg, L. Trinquart, G. Chatellier, A. Hagege, M. Desnos, and A. Lafont Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up Eur. Heart J., February 1, 2008; 29(3): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Hansen and N. Merchant MRI of Hypertrophic Cardiomyopathy: Part 2, Differential Diagnosis, Risk Stratification, and Posttreatment MRI Appearances Am. J. Roentgenol., December 1, 2007; 189(6): 1344 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cingolani, G. A. Ramirez Correa, E. Kizana, M. Murata, H. C. Cho, and E. Marban Gene Therapy to Inhibit the Calcium Channel {beta} Subunit: Physiological Consequences and Pathophysiological Effects in Models of Cardiac Hypertrophy Circ. Res., July 20, 2007; 101(2): 166 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lawrenz, F. Lieder, M. Bartelsmeier, C. Leuner, B. Borchert, D. Meyer zu Vilsendorf, C. Strunk-Mueller, J. Reinhardt, A. Feuchtl, C. Stellbrink, et al. Predictors of Complete Heart Block After Transcoronary Ablation of Septal Hypertrophy: Results of a Prospective Electrophysiological Investigation in 172 Patients With Hypertrophic Obstructive Cardiomyopathy J. Am. Coll. Cardiol., June 19, 2007; 49(24): 2356 - 2363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J Knight Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Heart, September 1, 2006; 92(9): 1339 - 1344. [Full Text] [PDF]
|
|
|
|
|
|
D. R. Talreja, R. A. Nishimura, W. D. Edwards, U. S. Valeti, S. R. Ommen, A. J. Tajik, J. A. Dearani, H. V. Schaff, and D. R. Holmes Jr Alcohol septal ablation versus surgical septal myectomy: Comparison of effects on atrioventricular conduction tissue J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2329 - 2332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Murata, E. Cingolani, A. D. McDonald, J. K. Donahue, and E. Marban Creation of a Genetic Calcium Channel Blocker by Targeted Gem Gene Transfer in the Heart Circ. Res., August 20, 2004; 95(4): 398 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Predicting Complete Heart Block After Alcohol Septal Ablation Journal Watch Cardiology, August 29, 2003; 2003(829): 4 - 4. [Full Text]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
